Volume 23, Number 11—November 2017
Dispatch
Virulence of Japanese Encephalitis Virus Genotypes I and III, Taiwan
Table 2
Region |
|||||||||
Characteristic |
Changhua |
Taipei |
Pingtung |
Miaoli |
Taichung |
Hualien |
Taichung |
Hualien |
p value† |
Year |
1994 |
1995 |
1999 |
2000 |
2010 |
2010 |
2012 |
2012 |
ND |
No. specimens (incidence of infection) |
966 (171) |
974 (88) |
638 (67) |
411 (137) |
656 (146) |
905 (151) |
632 (105) |
375 (75) |
ND |
NT positive, % |
62 |
69 |
60 |
58 |
65 |
75 |
72 |
66 |
<0.05 |
IgM positive, % (A) |
4.91 |
0.90 |
1.93 |
1.10 |
0.98 |
2.25 |
3.23 |
3.67 |
<0.05 |
Seroconversion +
≥4-fold increase in
NT titer, %‡ (B) |
0.58 |
1.13 |
0 |
0.73 |
1.37 |
1.32 |
0.95 |
1.33 |
>0.05 |
Incidence of infection, % (C = A + B) |
5.49 |
2.03 |
1.93 |
1.83 |
2.35 |
3.57 |
4.18 |
5.00 |
<0.05 |
Population§ (D) |
483,766 |
2,643,221 |
909,778 |
559,703 |
598,186 |
339,659 |
593,780 |
337,382 |
ND |
Predicted no. infections (E = C × D) |
26,559 |
53,657 |
17,559 |
10,243 |
14,057 |
12,126 |
24,820 |
16,869 |
ND |
Confirmed cases (F)¶ |
4 |
3 |
2 |
1 |
2 |
2 |
2 |
2 |
ND |
Asymptomatic ratio (G = F/E) |
1/6,640 |
1/17,886 |
1/8,779 |
1/10,243 |
1/7,029 |
1/6,063 |
1/12,410 |
1/8,435 |
>0.05 |
Asymptomatic ratio, 95% CI | 1/5,102–1/8,000 | 1/15,408–1/21,322 | 1/8,000–1/9,709 | 1/8,065–1/13,947 | 1/6,329–1/7,874 | 1/5,348–1/6,993 | 1/10,846–1/14,493 | 1/7,299–1/10,010 | ND |
*Serum samples were collected after the Japanese encephalitis season (May–September); multiple serum samples were collected from some participants. JEV, Japanese encephalitis virus; ND, no data; NT, neutralizing antibody.
†Analyzed by using one-way analysis of variance.
‡Among the IgM-negative population, JEV infection was estimated by the observation of an increase in the NT titer, including seroconversion and ≥4-fold increase in the NT titer among subjects with multiple serum samples.
§In Taichung, only residents of the districts around the serum-collecting hospital were included.
¶According to the official report of the Taiwan Centers for Disease Control.
1These authors contributed equally to this article.
Page created: October 17, 2017
Page updated: October 17, 2017
Page reviewed: October 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.